SkinBioTherapeutics to Seeking New CEO
On 2/14/19 SkinBioTherapeutics announced as part of its results through December 31 2018 that its current CEO, Dr Cath O'Neill, will be leaving her position. Dr O'Neill said, “I am very proud of everything that has been achieved by SkinBioTherapeutics in such a short time. Our ambition to enter the skin health market with a microbiome-based technology founded on a credible science, is progressing well. As a member of the Board, I am determined to find a suitable individual for the CEO role with the same passion for the science, as well as commercial acumen. Until someone is appointed, my priority is to continue to guide the Company through its first major human study and talks with potential partners.”
The announcement did not include a timeline for the replacement search.
If you want to keep up with current pharma and device news, please consider subscribing to our premium newsletter. The premium newsletter subscription includes access to our microbiome database. Subscriptions to just the database are also available.